Time to eradication ofMycoplasma genitaliumafter antibiotic treatment in men and women
Authors:
- 17 August 2015
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 70 (11) , 3134-3140
Abstract
The objectives of this study were to evaluate the time to a Mycoplasma genitalium-negative test after start of treatment and to monitor if and when antibiotic resistance developed. Sexually transmitted disease (STD) clinic attendees with suspected or verified M. genitalium infection were treated with azithromycin (5 days, 1.5 g; n = 85) or moxifloxacin (n = 5). Subjects with symptomatic urethritis or cervicitis of unknown aetiology were randomized to either doxycycline (n = 49) or 1 g of azithromycin as a single dose (n = 51). Women collected vaginal specimens and men collected first-catch urine 12 times during 4 weeks. Specimens were tested for M. genitalium with a quantitative MgPa PCR and for macrolide resistance-mediating mutations with a PCR targeting 23S rRNA. Clinical Trials Registration: NCT01661985. Ninety M. genitalium cases were enrolled. Of 56 patients with macrolide-susceptible strains before treatment with azithromycin (1.5 g, n = 46; 1 g single oral dose, n = 10), 54 (96%) had a negative PCR test within 8 days. In four patients, M. genitalium converted from macrolide susceptible to resistant after a 10 day lag time with negative tests (azithromycin 1.5 g, n = 3; 1 g single oral dose, n = 1). Moxifloxacin-treated subjects (n = 4) were PCR negative within 1 week. Six of eight (75%) remained positive despite doxycycline treatment. PCR for M. genitalium rapidly became negative after azithromycin treatment. Macrolide-resistant strains were detected after initially negative tests. Test of cure should be recommended no earlier than 3–4 weeks.Keywords
Funding Information
- Medical Research Council of Southeast Sweden
- County Council of Östergötland and by Linköpings Läkaresällskap
This publication has 28 references indexed in Scilit:
- Mycoplasma genitalium Testing Pattern and Macrolide Resistance: A Danish Nationwide Retrospective SurveyClinical Infectious Diseases, 2014
- High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment OptionsClinical Infectious Diseases, 2013
- Treatment of Mycoplasma genitalium. Observations from a Swedish STD ClinicPLOS ONE, 2013
- Standard Treatment Regimens for Nongonococcal Urethritis Have Similar but Declining Cure Rates: A Randomized Controlled TrialClinical Infectious Diseases, 2012
- Selection ofMycoplasma genitaliumstrains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin: Table 1Sexually Transmitted Infections, 2011
- Re-Evaluating the Treatment of Nongonococcal Urethritis: Emphasizing Emerging Pathogens-A Randomized Clinical TrialClinical Infectious Diseases, 2010
- A Randomized Comparison of Azithromycin and Doxycycline for the Treatment ofMycoplasma genitalium–Positive Urethritis in MenClinical Infectious Diseases, 2009
- Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trialSexually Transmitted Infections, 2008
- Azithromycin Failure inMycoplasma genitaliumUrethritisEmerging Infectious Diseases, 2006
- Tetracycline treatment does not eradicate Mycoplasma genitaliumSexually Transmitted Infections, 2003